GILEAD SCIENCES, INC.

data from 30/09/2025

Capitalization

$ 1.791 B 39.94 %

Average holding period

3 ans

Performance

$ 199.769 M 21.50 %

Capitalization

Portfolio size

Portfolio performance

Portfolio performance %

Performance compared to S&P 500 (%)

Stock in GILEAD SCIENCES, INC.

Date Ticket Name Weight Capitalization Share number First added Performance ($) Performance (%)
2025/09/30 GLPG GALAPAGOS NV 32.31% 578.747 M $ 16707477 2024/12/31 111.105 M $ 23.76 %
2025/09/30 ACLX ARCELLX INC 30.80% 551.778 M $ 6720803 2024/12/31 109.213 M $ 24.68 %
2025/09/30 RCUS ARCUS BIOSCIENCES INC 23.86% 427.377 M $ 31424760 2024/12/31 171.579 M $ 67.08 %
2025/09/30 ASMB ASSEMBLY BIOSCIENCES INC 6.44% 115.338 M $ 4505391 2024/12/31 16.527 M $ 41.28 %
2025/09/30 MRUS MERUS N V 2.38% 42.605 M $ 452527 2024/12/31 18.802 M $ 78.99 %
2025/09/30 TNGX TANGO THERAPEUTICS INC 2.28% 40.777 M $ 4854443 2024/12/31 15.923 M $ 64.06 %
2025/09/30 KYTX KYVERNA THERAPEUTICS INC 1.38% 24.757 M $ 4126119 2024/12/31 12.090 M $ 95.44 %
2025/09/30 XLO XILIO THERAPEUTICS INC 0.43% 7.673 M $ 9105451 2024/12/31 1.482 M $ 23.94 %
2025/09/30 LPTX LEAP THERAPEUTICS INC 0.13% 2.415 M $ 5319148 2024/12/31 835.638 K $ 52.91 %
2025/09/30 KLRS KALARIS THERAPEUTICS INC 0.00% 0.000 $ 0 2025/03/31 0.000 $ 0.00 %
2025/09/30 BARINTHUS BIOTHERAPEUTICS PL 0.00% 0.000 $ 0 2024/12/31 0.000 $ 0.00 %
2025/09/30 HOOK HOOKIPA PHARMA INC 0.00% 0.000 $ 0 2024/12/31 0.000 $ 0.00 %
2025/09/30 IKNA IKENA ONCOLOGY INC 0.00% 0.000 $ 0 2024/12/31 0.000 $ 0.00 %
2025/09/30 ALLO ALLOGENE THERAPEUTICS INC 0.00% 0.000 $ 0 2024/12/31 0.000 $ 0.00 %